Abano Healthcare Group Limited provides healthcare services in Australasia.
Limited growth and overvalued.
Share Price & News
How has Abano Healthcare Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ABA has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: ABA underperformed the NZ Healthcare industry which returned 32.7% over the past year.
Return vs Market: ABA underperformed the NZ Market which returned 21.9% over the past year.
Price Volatility Vs. Market
How volatile is Abano Healthcare Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 months ago | Simply Wall StImagine Owning Abano Healthcare Group (NZSE:ABA) And Wondering If The 45% Share Price Slide Is Justified
3 months ago | Simply Wall StWhat Does Abano Healthcare Group Limited's (NZSE:ABA) P/E Ratio Tell You?
4 months ago | Simply Wall StHere's Why Abano Healthcare Group (NZSE:ABA) Has A Meaningful Debt Burden
Is Abano Healthcare Group undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: ABA (NZ$5.36) is trading above our estimate of fair value (NZ$5.3)
Significantly Below Fair Value: ABA is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: ABA is poor value based on its PE Ratio (81.5x) compared to the Healthcare industry average (24.4x).
PE vs Market: ABA is poor value based on its PE Ratio (81.5x) compared to the NZ market (19.8x).
Price to Earnings Growth Ratio
PEG Ratio: ABA is poor value based on its PEG Ratio (4.5x)
Price to Book Ratio
PB vs Industry: ABA is good value based on its PB Ratio (1x) compared to the NZ Healthcare industry average (1.2x).
How is Abano Healthcare Group forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ABA's forecast earnings growth (17.9% per year) is above the savings rate (1.3%).
Earnings vs Market: ABA's earnings (17.9% per year) are forecast to grow faster than the NZ market (6.3% per year).
High Growth Earnings: ABA's earnings are forecast to grow, but not significantly.
Revenue vs Market: ABA's revenue (3.4% per year) is forecast to grow slower than the NZ market (5.1% per year).
High Growth Revenue: ABA's revenue (3.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ABA's Return on Equity is forecast to be low in 3 years time (6.7%).
How has Abano Healthcare Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ABA has a large one-off loss of NZ$8.3M impacting its November 30 2019 financial results.
Growing Profit Margin: ABA's current net profit margins (0.6%) are lower than last year (3.9%).
Past Earnings Growth Analysis
Earnings Trend: ABA's earnings have declined by -9.2% per year over the past 5 years.
Accelerating Growth: ABA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ABA had negative earnings growth (-83.5%) over the past year, making it difficult to compare to the Healthcare industry average (-2.9%).
Return on Equity
High ROE: ABA's Return on Equity (1.2%) is considered low.
Return on Assets
Return on Capital Employed
How is Abano Healthcare Group's financial position?
Financial Position Analysis
Short Term Liabilities: ABA's short term assets (NZ$27.1M) do not cover its short term liabilities (NZ$51.1M).
Long Term Liabilities: ABA's short term assets (NZ$27.1M) do not cover its long term liabilities (NZ$258.0M).
Debt to Equity History and Analysis
Debt Level: ABA's debt to equity ratio (97.3%) is considered high.
Reducing Debt: ABA's debt to equity ratio has increased from 95.2% to 97.3% over the past 5 years.
Debt Coverage: ABA's debt is well covered by operating cash flow (21.7%).
Interest Coverage: ABA's interest payments on its debt are not well covered by EBIT (2.6x coverage).
Inventory Level: ABA has a high level of physical assets or inventory.
Debt Coverage by Assets: ABA's debt is not covered by short term assets (assets are 0.2x debt).
What is Abano Healthcare Group's current dividend yield, its reliability and sustainability?
Forecast Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate ABA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate ABA's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ABA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ABA's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: ABA is not paying a notable dividend for the NZ market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ABA's dividend in 3 years as they are not forecast to pay a notable one for the NZ market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Richard Keys 0
Mr. Richard George Keys, BCom, CA has been Chief Executive Officer of Abano Healthcare Group Limited since November 2, 2015. Mr. Keys served as the Chief Financial Officer of Abano Healthcare Group Ltd. (f ...
CEO Compensation Analysis
Compensation vs Market: Richard's total compensation ($USD890.82K) is above average for companies of similar size in the NZ market ($USD272.37K).
Compensation vs Earnings: Richard's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
|Independent Deputy Chairman||0yrs||NZ$83.08k||0.065% NZ$91.0k|
|Independent Chairman of the Board||1.3yrs||NZ$130.30k||0.11% NZ$152.6k|
|Independent Director||3.5yrs||NZ$71.50k||0.039% NZ$55.0k|
|Independent Director||1.8yrs||NZ$78.38k||0.020% NZ$27.9k|
|Independent Director||0.9yrs||NZ$17.88k||no data|
Experienced Board: ABA's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Abano Healthcare Group Limited's company bio, employee growth, exchange listings and data sources
- Name: Abano Healthcare Group Limited
- Ticker: ABA
- Exchange: NZSE
- Founded: 1961
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: NZ$140.873m
- Shares outstanding: 26.28m
- Website: https://www.abano.co.nz
Number of Employees
- Abano Healthcare Group Limited
- AMP Centre
- Level 11
- New Zealand
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|ABA||NZSE (New Zealand Stock Exchange)||Yes||Ordinary Shares||NZ||NZD||Jan 1992|
Abano Healthcare Group Limited provides healthcare services in Australasia. It operates through Dental New Zealand and Diagnostics Australia. The company offers a range of general and specialist dental works, including restorative and cosmetic dental services. It operates approximately 239 dental practices. The company was formerly known as ElderCare New Zealand Limited and changed its name to Abano Healthcare Group Limited in August 2003. Abano Healthcare Group Limited was incorporated in 1961 and is based in Auckland, New Zealand.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/02/19 10:35|
|End of Day Share Price||2020/02/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.